stockmarketproxy
/
CGONNasdaq SEC EDGAR

CG Oncology, Inc.

Biological Products, (No Diagnostic Substances)·DALLAS, TX·FY end 12/31·CIK 1991792
OverviewFinancialsCompensationGovernanceInsidersFilings

Recent SEC filings

Showing 20View on EDGAR
10-Q2026-05-0810-Q8-K2026-05-088-KDEFA14A2026-04-24DEFA14ADEF 14A2026-04-24DEF 14A42026-04-20442026-04-16442026-04-16442026-04-16442026-04-16442026-04-1648-K2026-04-138-K42026-03-17442026-03-13xslF345X05/form4-03132026_080321.xml42026-03-06xslF345X05/form4-03062026_100310.xml10-K2026-02-2710-K8-K2026-02-278-K8-K2026-01-138-K42026-01-1348-K2026-01-098-K42025-11-264